Type-1 Diabetes Treatment Market: Key Growth Factors and Opportunity Analysis by 2027

 


MARKET SYNOPSIS

The Global Type-1 Diabetes Treatment Market is projected to grow from USD 5.6 Billion in 2018 to USD 9.6 Billion by 2025, registering a CAGR of 7.9%.

Type-1 diabetes is a chronic condition that requires lifelong medication. The onset of this condition usually occurs in childhood; it also affects obese and aged individuals.

This condition has been directly linked to a sedentary lifestyle, the adoption of which is widespread globally due to various societal, cultural, and economic factors. The rising prevalence of type-1 diabetes is driving the growth of the market.

Strict approvals processes are expected to hamper the growth of this market. However, this may be offset by the growing number of cases per year and increased government assistance for the management of the condition.

Get Sample Report: https://www.marketresearchfuture.com/sample_request/8199

MARKET USP

The enhanced efficacy of rapid-acting insulin and rising number of specialty treatment centers for type-1 diabetes are aggressively driving the growth of the market.

SEGMENTATION

·         By Product

·         Rapid-Acting Insulin: The rapid-acting insulin segment is expected to be the largest and fastest-growing during the review period. Usually taken before the ingestion of food or drink, rapid-action insulin is easy to introduce into the bloodstream and starts acting within 15 minutes of injection. The segment has been further classified as Admelog, Humalog, Novolog, and others.

·         Short-Acting Insulin: Also known as regular insulin, it is included in the World Health Organization’s list of essential medicines.

·         Medium-Acting Insulin: This growth of this segment is directly proportional to the growth of the short-acting insulin segment as these insulin types are usually taken concurrently.

·         Long-Acting Insulin: This is a growing segment as this type of insulin does not have a peak performance time and is equally effective for the entire duration. It is preferred by healthcare agencies due to its low side effects and gradual action. The segment has been further categorized as Lantus, Levemir, and others.

·         Others: Ultra long-term insulin and other experimental insulins are covered in this niche market segment. Though currently the smallest segment, it shows tremendous growth potential due to the numerous beneficial effects and limited side effects of these types of insulin. However, the growth of the segment is limited by stringent regulations, a rigorous testing process, and high costs.

By End User

·         Hospitals & Clinics: This is the largest and fastest-growing market segment and is projected to grow well beyond the forecast period. Hospitals and clinics are the primary care centers for individuals afflicted with type-1 diabetes; they are also cost-effective. Moreover, in countries with government-funded healthcare and a high prevalence of type-1 diabetes, hospitals and clinics are the main treatment centers, which is driving the growth of the segment.

·         Specialty Centers: A more specialized treatment option, specialty centers have mushroomed across the US and are being opened in India and China. This segment is growing due to the increased number of individuals afflicted with the condition and the higher returns on investment from specialty centers as compared to hospitals and clinics.

·         Others: The ease of availability and delivery of diabetes medication has led to patients opting for home treatment. The segment also covers old age homes as the geriatric population is highly susceptible to type-1 diabetes. A niche segment, it is expected to grow as awareness regarding the condition increases along with ease of treatment.

Access Report Details @ https://www.marketresearchfuture.com/reports/type-1-diabetes-treatment-market-8199

 

By Region

·         Americas: The largest market

·         Europe

·         Asia-Pacific: The fastest-growing regional market.

·         Middle East & Africa

 

KEY PLAYERS

·         Astellas Pharma (Japan)

·         Eli Lilly (US)

·         Merck (US)

·         Novo Nordisk (Denmark)

·         Sanofi (France)

·         AstraZeneca (UK)

·         Boehringer Ingelheim GmbH (Germany)

·         Novartis (Switzerland)

·         Pfizer Inc. (US)

·         Abbott Laboratories (US)

·         Mannkind Corporation (US)

·         Braun Melsungen AG (Germany)

·         Macrogenics, Inc. (US)

·         DiaVacs, Inc. (US)

·         Biodel, Inc. (US)

About US:

Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York,

New York 10013

Comments

Post a Comment

Popular posts from this blog

Bile Duct Cancer Market- Growth Opportunities by Manufacturers, Regions, Type, Application and Trends Forecast

Image
      Bile Duct Cancer Industry  – Overview Intensifying number of bile duct cancer cases being diagnosed globally have fortified the need for cutting-edge solutions in terms of procedure and medicines to treat the condition. Market reports associated with the healthcare sector made accessible by Market Research Future along with published reports on other sectors have been lately put out along with a report on this industry. The market is anticipated to develop at an increasing CAGR of 9.2 percent in the forecast period.   The mounting level of spending being devoted to research for the treatment of bile duct cancer is positively contributing to increasing the market share globally. This has allowed the development of pioneering procedures to treat this form of cancer apart from the traditional solution involving chemotherapy. Additionally, factors such as growing healthcare expenses and mounting awareness for the disease are projected to boost the progress of the market in th
Read more

Contrast Media Market 2022: Key Players, Market size, challenges, and opportunities

Image
  Contrast Media Market Research Report Market Overview The global Contrast Media Market is expected to grow at a CAGR of 3.7 percent to USD 5.9 billion by 2026, up from USD 4.9 billion in 2021. The rising frequency of chronic diseases, the increasing number of contrast agent approvals, the increasing amount of CT and MRI examinations conducted, the increasing number of diagnostic centers and hospitals, and the accessibility of reimbursement contribute to the Market's development. Players in the Market should expect excellent growth possibilities in emerging markets in Asian countries. Advanced therapies, on the other hand, may be limited in their market expansion due to their high cost and inaccessibility. The contrast media/contrast agents’ market is divided into administration routes, modalities, indications, end-users, applications, and regions. Get Sample Reports: https://www.marketresearchfuture.com/sample_request/1284 Contrast Media Market Competitive Landscape Ana
Read more

Syringe and Needle Market Trends and Executive Growth: 2022-2027, Regional Status, Business Demand and New Challenges till 2027

Image
  Growing Healthcare Sector in North America to Drive Syringe and Needle Market Rising Emphasis on Safety Innovations to Drive Syringe and Needle Market The global syringe and needle market is expected to exhibit a strong 7.3% CAGR over the forecast period from 2019 to 2025, according to the latest research report from Market Research Future (MRFR). The global syringe and needle market was valued at USD 6.4 billion in 2018 and is expected to rise to a valuation of more than USD 10.4 billion by 2025, according to the MRFR report. Get Sample Report: https://www.marketresearchfuture.com/sample_request/723 The report presents a detailed analysis of the global syringe and needle market by providing readers with a comprehensive overview of the market’s historical trajectory. The leading drivers and restraints affecting the global syringe and needle market are assessed in detail in the report. The historical impact of these drivers and restraints is analyzed in context of the curren
Read more